Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

G. Bisogno, G.L. De Salvo, C. Bergeron, J.H. Merks, A. Kelsey, H. Martelli, V. Minard-Colin, D. Orbach, H. Glosli, J. Chisholm, M. Casanova, I. Zanetti, C. Devalck, M. Ben-Arush, P. Mudry, S. Ferman, M. Jenney, A. Ferrari, Maria Soledad Angeles Gallego Melcon

Research output: Contribution to journalArticleResearchpeer-review

155 Citations (Scopus)
Original languageUndefined/Unknown
JournalThe Lancet Oncology
Publication statusPublished - 2019

Cite this